Literature DB >> 10987815

Characterisation of human adenylyl cyclase IX reveals inhibition by Ca(2+)/Calcineurin and differential mRNA plyadenylation.

J M Paterson1, S M Smith, J Simpson, O C Grace, A A Sosunov, J E Bell, F A Antoni.   

Abstract

The functional diversity of adenylyl cyclases provides for different modes of cyclic AMP signalling in mammals. This study reports the cloning and functional characterisation of a cDNA encoding human adenylyl cyclase IX (ACIX). The data show that human ACIX is a Ca(2+)/calcineurin-inhibited adenylyl cyclase prominently expressed in vital organs, including brain, heart, and pancreas. ACIX mRNA was detected in several brain regions, including neocortex, hippocampus, striatum, and cerebellum. By in situ hybridisation, ACIX mRNA was localised to pyramidal and granule cells of the hippocampus, indicating that it is expressed predominantly in nerve cells. Further analysis of ACIX mRNA expression revealed two major forms of ACIX mRNA that arose through tissue-specific differential mRNA polyadenylation. Taken together, the data show that (a) human ACIX is under inhibitory control by Ca(2+) through calcineurin, (b) ACIX may be involved in higher brain functions, and (c) post-transcriptional regulation of ACIX gene expression is a species-specific control mechanism that may enhance the versatility of cyclic AMP signalling in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987815     DOI: 10.1046/j.1471-4159.2000.0751358.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart.

Authors:  Yong Li; Lei Chen; Robert S Kass; Carmen W Dessauer
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

2.  Cellular localisation of adenylyl cyclase: a post-genome perspective.

Authors:  Ferenc A Antoni; Ulrich K Wiegand; Jamie Black; James Simpson
Journal:  Neurochem Res       Date:  2006-02       Impact factor: 3.996

3.  Insights into the Regulatory Properties of Human Adenylyl Cyclase Type 9.

Authors:  Tanya A Baldwin; Yong Li; Cameron S Brand; Val J Watts; Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2019-01-29       Impact factor: 4.436

4.  Functional characterization of the adenylyl cyclase gene sgs-1 by analysis of a mutational spectrum in Caenorhabditis elegans.

Authors:  Celine Moorman; Ronald H A Plasterk
Journal:  Genetics       Date:  2002-05       Impact factor: 4.562

5.  Direct stimulation of adenylyl cyclase 9 by the fungicide imidazole miconazole.

Authors:  James Simpson; Adrienn Pálvölgyi; Ferenc A Antoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-01-03       Impact factor: 3.000

6.  Effect of overexpressed adenylyl cyclase VI on beta 1- and beta 2-adrenoceptor responses in adult rat ventricular myocytes.

Authors:  Joalice C C Stark; Stephen F Haydock; Roger Foo; Morris J Brown; Sian E Harding
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

7.  Structural basis for inhibition of mammalian adenylyl cyclase by calcium.

Authors:  Tung-Chung Mou; Nanako Masada; Dermot M F Cooper; Stephen R Sprang
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

8.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 9.  Function of Adenylyl Cyclase in Heart: the AKAP Connection.

Authors:  Tanya A Baldwin; Carmen W Dessauer
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-16

10.  High adenylyl cyclase activity and in vivo cAMP fluctuations in corals suggest central physiological role.

Authors:  K L Barott; Y Helman; L Haramaty; M E Barron; K C Hess; J Buck; L R Levin; M Tresguerres
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.